Dupuytren Cords Do Not Undergo Significant Histopathological Change After Collagenase Clostridium Histolyticum Injection

Hand (N Y). 2023 Sep;18(6):912-917. doi: 10.1177/15589447211043204. Epub 2022 Jan 26.

Abstract

Background: Dupuytren disease creates thickened cords of the palmar fascia, leading to progressive flexion contractures that severely hinder hand function. Collagenase clostridium histolyticum (CCH) injection is a common, minimally invasive alternative to surgical excision of these cords. The impact of CCH injection on the histological architecture of Dupuytren cords has not been studied extensively. Methods: A series of 10 CCH-injected cords were evaluated histologically. Cellularity, architecture, and connective tissue organization were compared against uninjected Dupuytren cords and normal palmar fascia. Results: No significant histopathological differences between CCH-injected and CCH-uninjected cords were identified. Conclusions: Dupuytren cords do not demonstrate histological changes with prior exposure to CCH.

Keywords: Dupuytren disease; collagenase; hand contracture; histopathology; recurrent cord.

MeSH terms

  • Dupuytren Contracture* / drug therapy
  • Humans
  • Injections, Intralesional
  • Microbial Collagenase* / therapeutic use
  • Treatment Outcome

Substances

  • Microbial Collagenase